Boucherville, December 2, 2015 - Sandoz Canada is pleased to announce the launch of T/CLorazepam Injection USP 2 mg/mL, a new concentration now available in addition to its T/CLorazepam Injection USP 4 mg/mL. Lorazepam Injection USP (lorazepam) is indicated in adults for short-term relief of severe anxiety in patients with anxiety disorders, to relieve excessive anxiety before surgical procedures and to help control severe seizures (status epilepticus).
